BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23716996)

  • 21. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
    Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
    Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of serum abnormal prothrombin in clinical application of hepatocellular carcinoma].
    Zhang JW; Guan LY; E CY; Yang JH; Xuan W; Meng ZH; Li W
    Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):776-781. PubMed ID: 32993265
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
    Br J Cancer; 1995 Aug; 72(2):442-6. PubMed ID: 7543774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study.
    Wang K; Guo W; Li N; Shi J; Zhang C; Lau WY; Wu M; Cheng S
    Br J Cancer; 2014 Apr; 110(7):1811-9. PubMed ID: 24569461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
    Marrero JA; Feng Z; Wang Y; Nguyen MH; Befeler AS; Roberts LR; Reddy KR; Harnois D; Llovet JM; Normolle D; Dalhgren J; Chia D; Lok AS; Wagner PD; Srivastava S; Schwartz M
    Gastroenterology; 2009 Jul; 137(1):110-8. PubMed ID: 19362088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
    Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
    World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
    Montalto G; Iovanna JL; Soresi M; Dusetti N; Carroccio A; Barthelemy-Bialas S; Cartabellotta A; Dagorn JC
    Oncology; 1998; 55(5):421-5. PubMed ID: 9732219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
    Wang JJ; Cao EH
    Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
    Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
    World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
    López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
    Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
    Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
    Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
    Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
    World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
    Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
    Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.